Diagnos Laboratorium Utama Tbk. vs Saraswanti Anugerah Makmur Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Saraswanti Anugerah Makmur Tbk. trades at Rp278 (market cap 2.89T, 41.9K 24h volume). The key difference: Saraswanti Anugerah Makmur Tbk. is far larger — about 9.3× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 41.9K). Which is the better fit depends on your goals.
| DGNS | SAMF | |
|---|---|---|
Market Cap | 310.75B | 2.89T |
Volume | 963.6K | 41.9K |
Lot | 9.64K | 419 |
Turnover | 217.67M | 11.62M |
Average Price | 225.89 | 277.24 |
Value | 217.67M | 11.62M |
Indicative Equilibrium Price | 226 | 278 |
Indicative Equilibrium Volume | 1K | 30 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT. Saraswanti Anugerah Makmur Tbk. (the Company) was established based on the Notarial Deed of Titiek Lintang Trenggonowati, S.H., No.15 dated June 18, 1998, notary in Surabaya.
Read more on SAMF →